• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Annual Changes to the Nasdaq-100 Index®

    12/13/24 8:00:00 PM ET
    $AXON
    $ILMN
    $MRNA
    $MSTR
    Ordnance And Accessories
    Industrials
    Medical Specialities
    Health Care
    Get the next $AXON alert in real time by email

    NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (NASDAQ:NDX), which will become effective prior to market open on Monday, December 23, 2024.

    The following three companies will be added to the Index: Palantir Technologies Inc. (NASDAQ:PLTR), MicroStrategy Incorporated (NASDAQ:MSTR), and Axon Enterprise, Inc. (NASDAQ:AXON).

    The Nasdaq-100 Index® is composed of 100 of the largest non-financial companies1 listed on The Nasdaq Stock Market® and dates to January 1985 – nearly 40 years ago –when it was launched along with the Nasdaq Financial-100™ Index, which is comprised of 100 of the largest financial stocks on Nasdaq® These indexes act as benchmarks for financial products such as options, futures, and funds. The Nasdaq-100® is reconstituted each year in December, timed to coincide with the quadruple witch expiration Friday of the quarter.

    The Nasdaq-100 Index® is the basis of the Invesco QQQ Trust (NASDAQ:QQQ) which aims to provide investment results that, before expenses, correspond with the Nasdaq-100 Index® performance. In addition, options, futures and structured products based on the Nasdaq-100 Index® and the Invesco QQQ Trust trade on various exchanges.

    As a result of the reconstitution, the following three companies will be removed from the Index: Illumina, Inc. (NASDAQ:ILMN), Super Micro Computer, Inc. (NASDAQ:SMCI), and Moderna, Inc. (NASDAQ:MRNA).

    Information

    For information about the three companies to be added to the Nasdaq-100 Index®, please visit the following respective company websites:

    Palantir Technologies Inc. – https://www.palantir.com/

    MicroStrategy Incorporated – https://www.microstrategy.com/

    Axon Enterprise, Inc. – https://www.axon.com/

    About Nasdaq Global Indexes

    Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse. We continuously offer new opportunities for financial product sponsors across a wide spectrum of investable products and for asset managers to measure risk and performance. Nasdaq also provides exchange listing, custom index, and design solutions to financial organizations worldwide.

    _______________

    1 As outlined in the Nasdaq-100 Index® Methodology

    About Nasdaq

    Nasdaq (NASDAQ:NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions, and career opportunities, visit us on LinkedIn, on X, or at www.nasdaq.com. 

    The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither The Nasdaq OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq's proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

    - NDAQG - 

    Media Relations Contact Investor Relations Contact 
    Name: Jennifer Lawson

    Email: [email protected]

     Name: Index Client Services

    Email: [email protected]

     
        


    Primary Logo

    Get the next $AXON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AXON
    $ILMN
    $MRNA
    $MSTR

    CompanyDatePrice TargetRatingAnalyst
    Palantir Technologies Inc.
    $PLTR
    2/10/2026$180.00Neutral → Buy
    Daiwa Securities
    Palantir Technologies Inc.
    $PLTR
    2/3/2026$205.00Hold → Buy
    HSBC Securities
    Palantir Technologies Inc.
    $PLTR
    2/3/2026$190.00Market Perform → Outperform
    Northland Capital
    Palantir Technologies Inc.
    $PLTR
    2/3/2026$200.00Neutral → Outperform
    Robert W. Baird
    Palantir Technologies Inc.
    $PLTR
    2/2/2026Mkt Perform → Outperform
    William Blair
    Moderna Inc.
    $MRNA
    1/28/2026$25.00Equal Weight
    Barclays
    Strategy Inc
    $MSTR
    1/27/2026$213.00Overweight
    Cantor Fitzgerald
    Super Micro Computer Inc.
    $SMCI
    1/13/2026$26.00Sell
    Goldman
    More analyst ratings

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Gottlieb Scott bought $61,065 worth of shares (500 units at $122.13), increasing direct ownership by 4% to 12,523 units (SEC Form 4)

    4 - ILLUMINA, INC. (0001110803) (Issuer)

    11/5/25 4:05:20 PM ET
    $ILMN
    Medical Specialities
    Health Care

    Director Partovi Hadi bought $1,004,920 worth of shares (1,358 units at $740.00), increasing direct ownership by 0.57% to 237,938 units (SEC Form 4)

    4 - AXON ENTERPRISE, INC. (0001069183) (Issuer)

    8/15/25 4:36:59 PM ET
    $AXON
    Ordnance And Accessories
    Industrials

    Director Briger Peter L Jr bought $19,800,000 worth of Series A Perpetual Stretch Preferred Stock (220,000 units at $90.00) (SEC Form 4)

    4 - MICROSTRATEGY Inc (0001050446) (Issuer)

    7/29/25 6:20:52 PM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Angel Scott

    4 - Super Micro Computer, Inc. (0001375365) (Issuer)

    2/10/26 4:53:02 PM ET
    $SMCI
    Computer Manufacturing
    Technology

    SEC Form 4 filed by Sr. Corporate VP, Engineering Xiao Jin

    4 - Super Micro Computer, Inc. (0001375365) (Issuer)

    2/10/26 4:49:11 PM ET
    $SMCI
    Computer Manufacturing
    Technology

    SEC Form 4 filed by SVP, Chief Financial Officer Weigand David E

    4 - Super Micro Computer, Inc. (0001375365) (Issuer)

    2/10/26 4:47:13 PM ET
    $SMCI
    Computer Manufacturing
    Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date January 30, 2026

    NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- At the end of the settlement date of January 30, 2026, short interest in 3,547 Nasdaq Global MarketSM securities totaled 15,574,683,465 shares compared with 15,349,969,813 shares in 3,515 Global Market issues reported for the prior settlement date of January 15, 2026. The January short interest represents 2.58 days compared with 2.88 days for the prior reporting period. Short interest in 1,666 securities on The Nasdaq Capital MarketSM totaled 3,614,991,067 shares at the end of the settlement date of January 30, 2026, compared with 3,478,325,627 shares in 1,669 securities for the previous reporting period. This represents a 1.08 day average daily

    2/10/26 4:05:00 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Axon to Release Fourth Quarter 2025 Earnings on February 24, 2026

    SCOTTSDALE, Ariz., Feb. 10, 2026 /PRNewswire/ -- Axon (NASDAQ:AXON), the global public safety technology leader, today announced that it will report fourth quarter 2025 financial results after the market closes on Tuesday, February 24, 2026. Axon will host a live Zoom video webinar to discuss the company's financial results at 4:30 p.m. ET that same day. The live webinar is scheduled for 90 minutes and will include a presentation following the discussion of financial results, followed by Q&A. It will be linked from Axon's investor relations website at https://investor.axon.com

    2/10/26 4:01:00 PM ET
    $AXON
    Ordnance And Accessories
    Industrials

    Palantir and Airbus Extend Strategic Collaboration

    Palantir Technologies (NASDAQ:PLTR) is proud to announce the extension of its collaboration with Airbus through a multi-year agreement, confirming a relationship that has driven innovation across the aerospace industry for over a decade. Under this renewed contract, Airbus will continue to rely on Palantir for Skywise, its civil aviation open data platform. The Skywise platform enhances aircraft and equipment designs and enables greater efficiency, safety and sustainability in the production of civil aircraft across the Airbus industrial footprint. It also improves the performance of airlines' operations by combining in-flight engineering and operational data in an analytic rich environme

    2/10/26 4:01:00 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Moderna Inc.

    SCHEDULE 13G/A - Moderna, Inc. (0001682852) (Subject)

    2/9/26 10:48:12 AM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 10-Q filed by Super Micro Computer Inc.

    10-Q - Super Micro Computer, Inc. (0001375365) (Filer)

    2/6/26 5:03:49 PM ET
    $SMCI
    Computer Manufacturing
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Moderna Inc.

    SCHEDULE 13G/A - Moderna, Inc. (0001682852) (Subject)

    2/6/26 1:10:23 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Palantir Technologies upgraded by Daiwa Securities with a new price target

    Daiwa Securities upgraded Palantir Technologies from Neutral to Buy and set a new price target of $180.00

    2/10/26 7:57:53 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    Palantir Technologies upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded Palantir Technologies from Hold to Buy and set a new price target of $205.00

    2/3/26 12:10:56 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    Palantir Technologies upgraded by Northland Capital with a new price target

    Northland Capital upgraded Palantir Technologies from Market Perform to Outperform and set a new price target of $190.00

    2/3/26 7:57:56 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 30, 2020 - Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

    For Immediate Release: November 30, 2020 The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna, Inc. “In keeping with the FDA’s commitment to ensuring full transparency, dialogue and efficiency, the Vaccines and Related Biological Products Advisory Comm

    11/30/20 5:12:14 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Leadership Updates

    Live Leadership Updates

    View All

    Walmart Inc. to Join the Nasdaq-100 Index® Beginning January 20th, 2026

    NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that Walmart Inc. (NASDAQ:WMT), will become a component of the Nasdaq-100 Index® (NDX®), the Nasdaq-100 Equal Weighted™ Index (NDXE™), and the Nasdaq-100 Ex-Tech Sector™ Index (NDXX™) prior to market open on Tuesday, January 20, 2026 - the first trading day following the third Friday of the month. Walmart Inc. will replace AstraZeneca PLC (NASDAQ:AZN) in the Nasdaq-100 Index®, the Nasdaq-100 Equal Weighted Index, and the Nasdaq-100 Ex-Tech Sector Index. AstraZeneca PLC will also be removed from the Nasdaq-100 ESG™ Index (NDXESG™), Nasdaq-100 ex Top 30™​ (NDX70™), Nasdaq-100 ex Top 30​ UCITS™ (NDX70U™), Nasdaq

    1/9/26 8:00:00 PM ET
    $AZN
    $NDAQ
    $WMT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Bankers/Brokers/Service
    Finance

    Illumina Appoints Dr. Eric Green as Chief Medical Officer

    Veteran genomics leader joins Illumina to advance global medical strategyIllumina chief commercial officer to depart for role as a life science tools company CEO  SAN DIEGO, Jan. 8, 2026 /PRNewswire/ -- Today, Illumina, Inc. (NASDAQ:ILMN) announced the appointment of Eric D. Green, M.D., Ph.D., as Chief Medical Officer (CMO), effective February 2. In this role reporting to the CEO, Dr. Green will accelerate the company's mission to drive a revolution in medicine by unlocking the power of the genome. Dr. Green will serve as a key scientific and medical leader representing Illumina, helping advance the clinical use of genomics, expand access to precision medicine solutions, and increase the di

    1/8/26 4:30:00 PM ET
    $ILMN
    Medical Specialities
    Health Care

    Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026

    Planned Leadership Transition Positions Company for Growth Company Expects to Exceed Revenue and Cash Guidance for the Full Year 2025 Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that its Board of Directors (the "Board") has appointed Everett Cunningham as the Company's next President and Chief Executive Officer and a member of the Board, effective January 19, 2026. Mr. Cunningham will succeed Masoud Toloue, who will continue to serve as Chief Executive Officer until Mr. Cunningham assumes the role on January 19, 2026. Following Mr. Cunningham

    1/8/26 4:30:00 PM ET
    $ARVN
    $DGX
    $EXAS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical Specialities
    Biotechnology: Laboratory Analytical Instruments

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Financials

    Live finance-specific insights

    View All

    Axon to Release Fourth Quarter 2025 Earnings on February 24, 2026

    SCOTTSDALE, Ariz., Feb. 10, 2026 /PRNewswire/ -- Axon (NASDAQ:AXON), the global public safety technology leader, today announced that it will report fourth quarter 2025 financial results after the market closes on Tuesday, February 24, 2026. Axon will host a live Zoom video webinar to discuss the company's financial results at 4:30 p.m. ET that same day. The live webinar is scheduled for 90 minutes and will include a presentation following the discussion of financial results, followed by Q&A. It will be linked from Axon's investor relations website at https://investor.axon.com

    2/10/26 4:01:00 PM ET
    $AXON
    Ordnance And Accessories
    Industrials

    Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025

    Fourth quarter 2025 results: Revenue of $1.16 billion, up 5% from Q4 2024 (up 4% on a constant currency basis)Ex-China revenue of $1.10 billion, up 8% from Q4 2024 (up 7% on a constant currency basis)GAAP operating margin of 17.4% and non-GAAP operating margin of 23.7%GAAP diluted EPS of $2.16 and non-GAAP diluted EPS of $1.35Fiscal year 2025 results: Revenue of $4.34 billion, flat compared to 2024 on both a reported and constant currency basisEx-China revenue of $4.10 billion, up 2% from 2024 on both a reported and constant currency basisGAAP operating margin of 18.6% and non-GAAP operating margin of 23.1%GAAP diluted EPS of $5.45 and non-GAAP diluted EPS of $4.84Fiscal year 2026 guidance:

    2/5/26 4:06:00 PM ET
    $ILMN
    Medical Specialities
    Health Care

    Institutional-Grade Token Architecture Positions Companies at the Center of Digital Finance

    Scalable, compliant infrastructure supports demand for regulated digital assets for growing number of industries  Market News Updates News Commentary NEW YORK, Feb. 4, 2026 /PRNewswire/ -- Digital finance is moving fast, and institutional-grade token architecture is becoming a core piece of the financial system. Large investors and institutions want digital assets that are secure, compliant, and easy to integrate with traditional finance. Tokenized infrastructure built for institutions helps make that possible by supporting regulated transactions, asset-backed tokens, and scalable platforms designed for real-world use, not just experimentation as Active Companies take notice that may include

    2/4/26 8:45:00 AM ET
    $COIN
    $DJT
    $GNLN
    Finance: Consumer Services
    Finance
    Computer Software: Programming Data Processing
    Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Illumina Inc.

    SC 13G/A - ILLUMINA, INC. (0001110803) (Subject)

    12/6/24 10:11:24 AM ET
    $ILMN
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Illumina Inc.

    SC 13G - ILLUMINA, INC. (0001110803) (Subject)

    12/5/24 7:27:01 PM ET
    $ILMN
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by MicroStrategy Incorporated

    SC 13G - MICROSTRATEGY Inc (0001050446) (Subject)

    11/14/24 6:24:12 PM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology